Pfizer Execs Trade: R&D Chief Sells Shares, CEO Buys Phantom Units Amid Calm Market Sentiment
Pfizer insider moves: R&D president sells shares for taxes, CEO buys phantom units—confidence in pipeline but cautious market outlook.
3 minutes to read
Pfizer Inc
Pfizer CEO Albert Bourla Buys 79 Phantom Shares, Signaling Confidence in Company’s Pipeline—No Market Shock Expected
Albert Bourla’s recent phantom‑stock purchase shows steady confidence in Pfizer’s pipeline and long‑term value creation.
3 minutes to read